[HTML][HTML] Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2

CJ Peach, VW Mignone, MA Arruda… - International journal of …, 2018 - mdpi.com
Vascular endothelial growth factor-A (VEGF-A) is a key mediator of angiogenesis, signalling
via the class IV tyrosine kinase receptor family of VEGF Receptors (VEGFRs). Although …

Cardamonin: A new player to fight cancer via multiple cancer signaling pathways

J Nawaz, A Rasul, MA Shah, G Hussain, A Riaz… - Life sciences, 2020 - Elsevier
Nature's pharmacy has undoubtedly served humans as an affordable and safer health-care
regime for a long times. Cardamonin, a chalconoid present in several plants has been …

Targeted therapy for autoimmune diseases based on multifunctional frame nucleic acid system: blocking TNF-α-NF-κB signaling and mediating macrophage …

M Zhang, Y Wen, Z Huang, X Qin, M Zhou… - Chemical Engineering …, 2023 - Elsevier
Rheumatoid arthritis (RA), a chronic autoimmune disease (AD), can cause irreversible loss
of joint function. The methotrexate (MTX) is the first-line choice in the treatment of RA; …

[HTML][HTML] Antcin K inhibits TNF-α, IL-1β and IL-8 expression in synovial fibroblasts and ameliorates cartilage degradation: implications for the treatment of rheumatoid …

D Achudhan, SC Liu, YY Lin, CC Huang… - Frontiers in …, 2021 - frontiersin.org
Extracts from Taiwan's traditional medicinal mushroom, Antrodia cinnamomea, exhibit anti-
inflammatory activities in cellular and preclinical studies. However, this paper is the first to …

Advances and challenges in hemophilic arthropathy

T Wyseure, LO Mosnier, A von Drygalski - Seminars in hematology, 2016 - Elsevier
Hemophilic arthropathy is a form of joint disease that develops secondary to joint bleeding
and presents with synovial hypertrophy, cartilage and bony destruction. The arthropathy can …

[HTML][HTML] Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis

P Di Benedetto, P Ruscitti, O Berardicurti… - Arthritis Research & …, 2021 - Springer
Objective During rheumatoid arthritis (RA), the angiogenic processes, occurring with pannus-
formation, may be a therapeutic target. JAK/STAT-pathway may play a role and the aim of …

[HTML][HTML] Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis

S Hua, TH Dias - Frontiers in pharmacology, 2016 - frontiersin.org
Hypoxia is an important micro-environmental characteristic of rheumatoid arthritis (RA).
Hypoxia-inducible factors (HIF) are key transcriptional factors that are highly expressed in …

Drug delivery targets and systems for targeted treatment of rheumatoid arthritis

X Feng, Y Chen - Journal of drug targeting, 2018 - Taylor & Francis
Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease that selectively
attacks human joints. The common non-targeted treatment approaches lead to obvious side …

CCN1 promotes VEGF production in osteoblasts and induces endothelial progenitor cell angiogenesis by inhibiting miR‐126 expression in rheumatoid arthritis

CY Chen, CM Su, CJ Hsu, CC Huang… - Journal of Bone and …, 2017 - academic.oup.com
Angiogenesis is the formation of new capillaries from preexisting vasculature. The
perpetuation of angiogenesis plays a critical role in the pathogenesis of various disease …

Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis

EM Sabi, A Singh, ZM Althafar, T Behl, A Sehgal… - …, 2022 - Springer
Rheumatoid arthritis (RA) is a chronic multifactorial disease, provocative, and degenerative
autoimmune condition that impacts millions of individuals around the globe. As a result of …